Javier Arpa

3.1k total citations
83 papers, 1.7k citations indexed

About

Javier Arpa is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Neurology. According to data from OpenAlex, Javier Arpa has authored 83 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Cellular and Molecular Neuroscience, 33 papers in Molecular Biology and 28 papers in Neurology. Recurrent topics in Javier Arpa's work include Genetic Neurodegenerative Diseases (32 papers), Mitochondrial Function and Pathology (25 papers) and Hereditary Neurological Disorders (11 papers). Javier Arpa is often cited by papers focused on Genetic Neurodegenerative Diseases (32 papers), Mitochondrial Function and Pathology (25 papers) and Hereditary Neurological Disorders (11 papers). Javier Arpa collaborates with scholars based in Spain, United States and Germany. Javier Arpa's co-authors include A Cruz-Martı́nez, Irene Sanz‐Gallego, Francesc Palau, Francisco Javier Rodríguez de Rivera Garrido, Albert Saiz, Francesc Graus, Inés González‐Suarez, Eduardo Tolosa, Roser Casamitjana and J.J. Zarranz and has published in prestigious journals such as SHILAP Revista de lepidopterología, Neurology and Annals of Neurology.

In The Last Decade

Javier Arpa

83 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Javier Arpa Spain 20 798 791 583 187 179 83 1.7k
Florian Stögbauer Germany 25 377 0.5× 525 0.7× 410 0.7× 158 0.8× 113 0.6× 69 1.8k
Keiko Kamakura Japan 26 572 0.7× 546 0.7× 756 1.3× 197 1.1× 70 0.4× 67 2.0k
Antonio Di Muzio Italy 24 584 0.7× 591 0.7× 450 0.8× 129 0.7× 146 0.8× 81 1.6k
Kevin J. Felice United States 23 350 0.4× 686 0.9× 643 1.1× 171 0.9× 77 0.4× 65 1.7k
Marco Luigetti Italy 27 609 0.8× 1.2k 1.5× 1.1k 2.0× 172 0.9× 271 1.5× 169 2.5k
Franco Gemignani Italy 27 741 0.9× 1.2k 1.5× 289 0.5× 137 0.7× 123 0.7× 78 2.0k
Jean‐Philippe Camdessanché France 25 463 0.6× 1.5k 1.8× 300 0.5× 77 0.4× 106 0.6× 101 2.0k
Christiane Schneider‐Gold Germany 29 1.2k 1.4× 1.4k 1.7× 984 1.7× 73 0.4× 139 0.8× 77 2.3k
David Saperstein United States 21 824 1.0× 1.4k 1.7× 340 0.6× 140 0.7× 344 1.9× 60 2.2k
Camiel Verhamme Netherlands 20 606 0.8× 521 0.7× 340 0.6× 103 0.6× 230 1.3× 53 1.2k

Countries citing papers authored by Javier Arpa

Since Specialization
Citations

This map shows the geographic impact of Javier Arpa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Javier Arpa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Javier Arpa more than expected).

Fields of papers citing papers by Javier Arpa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Javier Arpa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Javier Arpa. The network helps show where Javier Arpa may publish in the future.

Co-authorship network of co-authors of Javier Arpa

This figure shows the co-authorship network connecting the top 25 collaborators of Javier Arpa. A scholar is included among the top collaborators of Javier Arpa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Javier Arpa. Javier Arpa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Arias, Manuel, Pablo Mir, Marta Fernández‐Matarrubia, et al.. (2021). Autosomal recessive spinocerebellar ataxia SCAR8/ARCA1: first families detected in Spain. SHILAP Revista de lepidopterología. 37(4). 257–262. 1 indexed citations
2.
Cacheiro, Pilar, Andrés Ordóñez‐Ugalde, Beatriz Quintáns, et al.. (2017). Evaluating the Calling Performance of a Rare Disease NGS Panel for Single Nucleotide and Copy Number Variants. Molecular Diagnosis & Therapy. 21(3). 303–313. 6 indexed citations
3.
Gutiérrez‐Rivas, Eduardo, Juan Bautista, Juan J. Vílchez, et al.. (2015). Dried Blood Spot for Screening for Late-Onset Pompe Disease: A Spanish Cohort. Journal of Neuromuscular Diseases. 2(s1). S42–S42. 2 indexed citations
4.
Gutiérrez‐Rivas, Eduardo, J. Bautista, Juan J. Vílchez, et al.. (2015). Targeted screening for the detection of Pompe disease in patients with unclassified limb-girdle muscular dystrophy or asymptomatic hyperCKemia using dried blood: A Spanish cohort. Neuromuscular Disorders. 25(7). 548–553. 43 indexed citations
5.
Martínez‐Sánchez, Patricia, et al.. (2015). Substantia Nigra Echogenicity in Hereditary Ataxias With and Without Nigrostriatal Pathology: a Pilot Study. The Cerebellum. 14(3). 240–246. 2 indexed citations
6.
Illán‐Gala, Ignacio, et al.. (2015). Evolución a largo plazo de la hidrocefalia crónica del adulto idiopática tratada con válvula de derivación ventrículo-peritoneal. Neurología. 32(4). 205–212. 11 indexed citations
7.
González‐Suarez, Inés, et al.. (2013). Leukoencephalopathy due to Oral Methotrexate. The Cerebellum. 13(1). 178–183. 17 indexed citations
8.
Mazón, Marı́a J., Francisco Barros, Pilar de la Peña, et al.. (2011). Screening for mutations in Spanish families with myotonia. Functional analysis of novel mutations in CLCN1 gene. Neuromuscular Disorders. 22(3). 231–243. 30 indexed citations
9.
Garrido, Francisco Javier Rodríguez de Rivera, et al.. (2011). Evolución de pacientes con esclerosis lateral amiotrófica atendidos en una unidad multidisciplinar. Neurología. 26(8). 455–460. 26 indexed citations
10.
Arpa, Javier, Yolanda Campos, A Cruz-Martı́nez, et al.. (2009). Benign mitochondrial myopathy with decreased succinate cytochrome C reductase activity. Acta Neurologica Scandinavica. 90(4). 281–284. 3 indexed citations
11.
Martínez, A. Cruz, et al.. (2009). Transcranial magnetic stimulation in multiple system and late onset cerebellar atrophies. Acta Neurologica Scandinavica. 92(3). 218–224. 9 indexed citations
12.
Arpa, Javier, Ana Cuesta, A Cruz-Martı́nez, et al.. (2009). Clinical features and genetic analysis of a Spanish family with spinocerebellar ataxia 6. Acta Neurologica Scandinavica. 99(1). 43–47. 13 indexed citations
13.
Benito‐León, Julián, et al.. (2007). Isolated CNS Whipple disease: Acute onset and relapsing-remitting course. Scandinavian Journal of Infectious Diseases. 39(6-7). 623–625. 7 indexed citations
14.
Barrio, M, et al.. (2002). Neuralgic amyotrophy: variable expression in 40 patients. Journal of the Peripheral Nervous System. 7(3). 198–204. 64 indexed citations
15.
Cruz-Martı́nez, A, et al.. (2000). Quadriceps Atrophy after Knee Traumatisms and Immobilization: Electrophysiological Assessment. European Neurology. 43(2). 110–114. 18 indexed citations
16.
Arpa, Javier, et al.. (1998). Centralis superior raphe, reticularis pontis nuclei, and sleep‐wakefulness cycle in cats. Journal of Sleep Research. 7(4). 263–275. 4 indexed citations
17.
18.
Díez‐Tejedor, Exuperio, et al.. (1996). [Acute cervical ischemic myelopathy: anterior spinal artery syndrome].. PubMed. 196(4). 234–6. 4 indexed citations
19.
Arpa, Javier, et al.. (1994). [Idiopathic granulomatous angiitis of the central nervous system].. PubMed. 9(9). 423–6. 16 indexed citations
20.
Garcı́a-Merino, A., et al.. (1992). IgG anti-ganglioside antibodies and their subclass distribution in two patients with acute and chronic motor neuropathy. Journal of Neuroimmunology. 37(1-2). 141–148. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Florian Stögbauer Breakdown of academic impact, for papers by Keiko Kamakura Breakdown of academic impact, for papers by Antonio Di Muzio Breakdown of academic impact, for papers by Kevin J. Felice Breakdown of academic impact, for papers by Marco Luigetti Breakdown of academic impact, for papers by Franco Gemignani Breakdown of academic impact, for papers by Jean‐Philippe Camdessanché Breakdown of academic impact, for papers by Christiane Schneider‐Gold Breakdown of academic impact, for papers by David Saperstein Breakdown of academic impact, for papers by Camiel Verhamme
Rankless by CCL
2026